A. A. Gaitan

Neuroinflammation as a Final Common Pathway in Systemic Disease — How Systemic Disease Becomes Brain Disease

Recognizing neuroinflammation as this final common pathway reframes diagnosis around shared biomarkers rather than disease labels, predicts cross-disease therapeutic benefit, and relocates the therapeutic window earlier—toward protecting a brain vulnerable long before overt neurological disease declares itself.